Mancini v. Accredo Health Group, Inc

CourtDistrict Court, D. Connecticut
DecidedSeptember 4, 2019
Docket3:17-cv-01625
StatusUnknown

This text of Mancini v. Accredo Health Group, Inc (Mancini v. Accredo Health Group, Inc) is published on Counsel Stack Legal Research, covering District Court, D. Connecticut primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Mancini v. Accredo Health Group, Inc, (D. Conn. 2019).

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF CONNECTICUT

AMANDA MANCINI, : Plaintiff, : CASE NO. 3:17-CV-01625-MPS : v. : : ACCREDO HEALTH GROUP, INC., : Defendants. : September 4, 2019 ________________________________________________________________________ RULING ON MOTION FOR SUMMARY JUDGMENT I. Introduction The Plaintiff, Amanda Mancini, filed this action challenging a decision by Accredo Health Group to terminate her employment as an infusion nurse. In her complaint, Mancini alleges retaliation in violation of the Family and Medical Leave Act, disability discrimination in violation of the Americans with Disabilities Act, and disability discrimination in violation of the Connecticut Fair Employment Practices Act. (ECF No. 1.) Accredo has moved for summary judgment on all counts. (ECF No. 24.) For the reasons set forth below, the motion for summary judgment is GRANTED as to the ADA claim and the CFEPA claim, and DENIED as to the FMLA claim. II. Factual Background The following facts, which are taken from the parties' Local Rule 56(a) Statements and the exhibits, are undisputed unless otherwise indicated. A. Mancini’s Position with Accredo Plaintiff Amanda Mancini began working for Defendant Accredo Health Group on or about November 24, 2014 as an Infusion Nurse. (ECF No. 25-11 (“Def.'s L.R.

1 A redacted version of the Defendant’s Local Rule 56(a)(1) statement has been posted to the docket as ECF No. 24-2. 56(a)(1) Stmt.”) at ¶ 9; ECF No. 27-11 (“Pl.’s L.R. 56(a)(2) Stmt.”) at ¶ 9.) Mancini’s primary function as an Infusion Nurse was to provide in-home intravenous (“IV”) infusion medical treatment and to assist patients with administering their medications. (Def.'s L.R. 56(a)(1) Stmt. at ¶ 12; Pl.’s L.R. 56(a)(2) Stmt. at ¶ 12.)

Generally, during a home visit, Mancini would first ensure that a patient’s IV line was correctly in place and connected to a hep-lock. (Def.'s L.R. 56(a)(1) Stmt. at ¶ 14; Pl.’s L.R. 56(a)(2) Stmt. at ¶ 14.) A “hep-lock,” also known as a “saline lock,” is an “intravenous portal, usually placed and left in a vein in one of the patient’s arms, and used episodically for fluid or medication infusions.” Saline Lock, Medical Dictionary, http://medical-dictionary.thefreedictionary.com/saline+lock (last visited Aug. 29, 2019). If a patient already had a hep-lock in place, Mancini would ensure that the patient’s hep- lock was adequately functioning by flushing it with saline solution. (Def.'s L.R. 56(a)(1) Stmt. at ¶ 14; Pl.’s L.R. 56(a)(2) Stmt. at ¶ 14.) If a patient did not already have a hep- lock in place, Mancini would be responsible for inserting one. (Def.'s L.R. 56(a)(1) Stmt.

at ¶ 15; Pl.’s L.R. 56(a)(2) Stmt. at ¶ 15.) In order to insert a hep-lock, Mancini would attempt to locate a vein, insert a peripheral intravenous catheter with a needle, and then remove the needle so as to leave only the catheter in the patient’s vein. (Def.'s L.R. 56(a)(1) Stmt. at ¶ 16; Pl.’s L.R. 56(a)(2) Stmt. at ¶ 16.) If unable to properly insert the hep-lock into a vein, Mancini would attempt to do so again by fully removing the needle from the vein and inserting it in a different location. (Def.'s L.R. 56(a)(1) Stmt. at ¶ 17- 18; Pl.’s L.R. 56(a)(2) Stmt. at ¶ 17-18.) Under Accredo’s policy, Mancini was allowed to make three attempts at inserting the hep-lock before having to call a separate infusion nurse for additional assistance. (Def.'s L.R. 56(a)(1) Stmt. at ¶ 19; Pl.’s L.R. 56(a)(2) Stmt. at ¶ 19.) Once an IV line was secured and a patient’s vitals were reading normally, Mancini would then open and mix the patient’s medication. (Def.'s L.R. 56(a)(1) Stmt. at ¶ 20; Pl.’s L.R. 56(a)(2) Stmt. at ¶ 20.) After administering the patient’s medication, Mancini was responsible for disposing of all garbage, including gauze, alcohol swabs,

and wrappers, into the patient’s waste can, and disposing of all needles into a “sharps” container. (Def.'s L.R. 56(a)(1) Stmt. at ¶ 21; Pl.’s L.R. 56(a)(2) Stmt. at ¶ 21.) B. Mancini’s Request for FMLA Leave On March 22, 2016, Mancini requested intermittent leave under the FMLA through AON Hewitt, a third-party vendor that handled FMLA leave requests for Accredo. (Def.'s L.R. 56(a)(1) Stmt. at ¶ 30-31; Pl.’s L.R. 56(a)(2) Stmt. at ¶ 30-31.) Mancini suffers from adrenal insufficiency, leukocytosis, and thrombocytosis, for which she has been hospitalized several times. (ECF No. 27-2 (“Pl.’s Aff.”) at ¶ 82.) AON approved Mancini for intermittent leave for a maximum of ten times per month, with each absence allowed up to a full day. (Def.'s L.R. 56(a)(1) Stmt. at ¶ 32; Pl.’s L.R.

56(a)(2) Stmt. at ¶ 32.) On the same day, Mancini requested and AON approved FMLA leave for April 8, 2016. (ECF No. 24-3 at 13; Pl.’s Aff. at ¶ 42.) According to Accredo, Mancini was pre-approved for intermittent leave, and the only further requirement was that she report her FMLA absences to AON Hewitt no later than 11:59 pm on the day of the absence. (Def.'s L.R. 56(a)(1) Stmt. at ¶ 33; ECF No. 24-1 at 3, 18.) According to Mancini, however, on the evening of March 22, 2016—the same day she was approved for intermittent leave—Mancini received a phone call from her supervisor, Lois Klansek, who confronted her about scheduling a day of intermittent leave for April 8, 2016 for a doctor’s appointment. (Pl.’s Aff. at ¶¶ 48-49.) Klansek told Mancini that before she scheduled any days off, she had to first report to Klansek and obtain her clearance, because another nurse had been given April 8 off, and Klansek had “no nurses to cover Southeastern Connecticut.” (Id. at ¶¶ 48-49.) Mancini also claims Klansek told her that going to AON for FMLA approval without going to her first was

not “being a team player” because once AON approved a request for leave, Klansek could not deny it. (Id. at ¶ 49.) C. Mancini’s April 6 Appointments On April 6, 2016, Mancini was scheduled to visit three patients. (Def.'s L.R. 56(a)(1) Stmt. at ¶ 36; Pl.’s L.R. 56(a)(2) Stmt. at ¶ 36.) When Mancini arrived at the first patient’s home, she was feeling “feverish, flushed, and weak, and was profusely sweating.” (Def.'s L.R. 56(a)(1) Stmt. at ¶ 40; Pl.’s L.R. 56(a)(2) Stmt. at ¶ 40.) The patient already had a hep-lock inserted, but when Mancini flushed it with saline solution to ensure it was adequately working, she “received resistance from the saline solution on three separate flushes,” so she determined she had to reinsert the hep-lock in another

location. (Def.'s L.R. 56(a)(1) Stmt. at ¶ 43; Pl.’s L.R. 56(a)(2) Stmt. at ¶ 43.) She “spent about an hour and a half flushing the saline solution despite it normally taking fifteen minutes.” (Def.'s L.R. 56(a)(1) Stmt. at ¶ 44; Pl.’s L.R. 56(a)(2) Stmt. at ¶ 44.) Mancini made at least three attempts at “sticking the patient’s vein,” but was unsuccessful. (Def.'s L.R. 56(a)(1) Stmt. at ¶¶ 46, 48; Pl.’s L.R. 56(a)(2) Stmt. at ¶¶ 46, 48.) The patient’s family reported that Mancini made at least five attempts (Def.'s L.R. 56(a)(1) Stmt. at ¶ 49), but Mancini claims to have only made three attempts (Pl.’s Aff. at ¶ 50). In either case, Mancini eventually telephoned another nurse, Karen Chasse, to request assistance. (Def.'s L.R. 56(a)(1) Stmt. at ¶ 53; Pl.’s L.R. 56(a)(2) Stmt. at ¶ 53.) According to Chasse, when she arrived, “the house was in disarray with IV supplies scattered across several surfaces,” and the family of the patient told her “that Mancini had previously fallen into the refrigerator.” (ECF No. 24-5 at ¶ 8.) Accredo also claims that the patient’s family told Chasse that Mancini “looked scary” with

“Parkinson like movements” and that Mancini “left a bloody gauze on the couch” as well as used needles on the floor and coffee table. (Def.'s L.R. 56(a)(1) Stmt.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

McCarthy v. Dun & Bradstreet Corp.
482 F.3d 184 (Second Circuit, 2007)
McDonnell Douglas Corp. v. Green
411 U.S. 792 (Supreme Court, 1973)
Henry v. Wyeth Pharmaceuticals, Inc.
616 F.3d 134 (Second Circuit, 2010)
El Sayed v. Hilton Hotels Corp.
627 F.3d 931 (Second Circuit, 2010)
James M. Cronin v. Aetna Life Insurance Company
46 F.3d 196 (Second Circuit, 1995)
Joseph v. Treglia v. Town of Manlius
313 F.3d 713 (Second Circuit, 2002)
Peter Potenza, Clifford Aversano v. City of New York
365 F.3d 165 (Second Circuit, 2004)
McElwee v. County of Orange
700 F.3d 635 (Second Circuit, 2012)
Kwan v. The Andalex Group LLC
737 F.3d 834 (Second Circuit, 2013)
Tolan v. Cotton
134 S. Ct. 1861 (Supreme Court, 2014)
Woods v. Start Treatment & Recovery Centers, Inc.
864 F.3d 158 (Second Circuit, 2017)
Baron v. Advanced Asset & Property Management Solutions, LLC
15 F. Supp. 3d 274 (E.D. New York, 2014)
Marini v. Costco Wholesale Corp.
64 F. Supp. 3d 317 (D. Connecticut, 2014)
DeAngelo v. Yellowbook Inc.
105 F. Supp. 3d 166 (D. Connecticut, 2015)
Vale v. City of New Haven
197 F. Supp. 3d 389 (D. Connecticut, 2016)
McPherson v. New York City Department of Education
457 F.3d 211 (Second Circuit, 2006)
Moll v. Telesector Resources Group, Inc.
760 F.3d 198 (Second Circuit, 2014)
Natofsky v. City Of New York
921 F.3d 337 (Second Circuit, 2019)
Trent v. Town of Brookhaven
966 F. Supp. 2d 196 (E.D. New York, 2013)

Cite This Page — Counsel Stack

Bluebook (online)
Mancini v. Accredo Health Group, Inc, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mancini-v-accredo-health-group-inc-ctd-2019.